Skip to content ↓

Topic

Genetic engineering

Download RSS feed: News Articles / In the Media / Audio

Displaying 31 - 39 of 39 news clips related to this topic.
Show:

The Washington Post

Washington Post reporter Joel Achenbach writes that a committee co-chaired by Prof. Richard Hynes has presented a series of guidelines for applying CRISPR gene editing in humans. “We say proceed with all due caution, but we don’t prohibit germline, after considerable discussion and debate,” says Hynes. “We’re talking only about fixing diseases.”

Slate

In an article for Slate, Prof. Kevin Esvelt argues for the importance of keeping scientific research open and publically accessible, in particular when it comes to gene editing. “Scientific journals, funders, policymakers, and intellectual property holders should change the incentives to ensure that all proposed gene drive experiments are open and responsive,” writes Esvelt.

CBS Boston

Mike LaCrosse of WBZ-TV News spotlights Broad Institute research affiliate Theresa Oei and her work both in the lab and on the field as a cheerleader for the Patriots. Oei says she enjoys sharing her love of science with children, adding that “leaving the path to science open is really important, and showing that it can be a lot of fun.” 

The New Yorker

In this piece for The New Yorker, Michael Specter writes about Prof. Kevin Esvelt’s idea to use gene-editing technology to eradicate Lyme disease. “This is an ecological problem,” Esvelt explains. “And we want to enact an ecological solution so that we break the transmission cycle that keeps ticks in the environment infected with these pathogens.”

WBUR's CommonHealth

Prof. Kevin Esvelt is taking his genetically modified mice proposal for fighting Lyme disease to Martha’s Vineyard, says Carey Goldberg of WBUR. “Everyone would agree we should decide this in New England town hall debate at the local level, rather than handing it over to scientists like me to make unilateral decisions. I’m not for that,” says Prof. Esvelt

New Scientist

Michael Le Page writes for New Scientist that MIT researchers have developed a technique that allows cells to log their activities using the CRISPR gene-editing system. Le Page explains that “such CRISPR-based logging could have a huge range of uses, from smart cells that monitor our health from within, to helping us understand exactly how our bodies develop.”

WBUR

Professor Kenneth Oye speaks with WBUR’s Sacha Pfeiffer about his recent research that details a new way to alter the genomes of organisms and the need for a public discussion about the potential implications and benefits of this new technology. 

Financial Times

Three scientific papers about the Y chromosome, which determines maleness in humans and most other mammals, should lay to rest the myth that it may disappear after a few more million years of evolution,” Financial Times reporter Clive Cookson writes of MIT research on the Y chromosome.

Nature

Professor Ron Weiss contributes to this article in Nature on how to overcome the greatest obstacles in the field of synthetic biology. Weiss recommends improving the efficiency of the design of genetic parts.